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ABSTRACT New lines of evidence suggest that volatile anesthetics interact specifically with proteins. Direct binding
analysis, however, has been largely limited to soluble proteins. In this study, specific interaction was investigated between
isoflurane, a clinically important volatile anesthetic, and membrane-bound nicotinic acetylcholine receptors (nAChRs) from
Torpedo electroplax, using 19F nuclear magnetic resonance spectroscopy and gas chromatography. The receptors were
reconstituted into 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) lipid vesicles. After correcting for nonspecific partition-
ing into the lipid, the equilibrium dissociation constant, Kd, of isoflurane binding to nAChR at 15°C was found to be 0.36 
0.03 mM. This value is within the clinically relevant concentration range of the agent. Based on the receptor concentrations
in the vesicle suspension assayed by the bicinchoninic acid method and the fraction of bound isoflurane, Xb, determined by
gas chromatography, an estimate of an average of 9–10 specifically bound isoflurane molecules can be made for each
receptor, or two for each subunit. Upon binding, the transverse relaxation time constant (T2) of
19F resonance of isoflurane
is decreased by nearly three orders of magnitude, indicating a dramatic reduction in the mobility of specifically bound
isoflurane. Kinetic analysis reveals that the off rate of binding, k1, is 1.7  10
4 s1. The on rate, k1, can thus be calculated
to be 4.8  107 M1 s1, suggesting a nearly diffusion-limited association. This is in contrast to anesthetic binding to a
soluble protein, bovine serum albumin (BSA), where k1 and k1 are at least an order of magnitude slower. It is concluded
that the presence of lipids may be critical for the correct evaluation of binding kinetics between volatile anesthetics and
neuronal receptors.
INTRODUCTION
There is a growing consensus that general anesthetics inter-
act with neuronal proteins (Eckenhoff and Johansson, 1997;
Franks and Lieb, 1994). Electrophysiological studies have
indicated that a superfamily of neurotransmitter-gated ion
channels, including the nicotinic acetylcholine receptors
(nAChRs), -aminobutyric acidA (GABAA) receptors, gly-
cine receptors, and 5-hydroxytryptamine (5-HT3) receptors,
is particularly sensitive to general anesthetics (Franks and
Lieb, 1996). Site-directed mutagenesis has implicated the
existence of an inhibitory site within the aqueous pore of
nAChR (Forman et al., 1995) and a potentiating site at the
extracellular interfacial regions of transmembrane domains
2 and 3 (MII-MIII) on the glycine and GABAA receptors
(Mihic et al., 1997). Although these studies clearly indicate
the involvement of these critical residues in anesthetic ac-
tion, it remains unknown whether direct anesthetic binding
to the receptor is involved in the anesthetic action.
Indeed, experimental results on binding between volatile
anesthetics and membrane proteins are scarce. Photoaffinity
labeling of [14C]halothane, a clinically important inhala-
tional anesthetic, to native Torpedo membranes and isolated
nAChR (Eckenhoff, 1996b) suggests that halothane binding
to nAChR is saturable and that the conformational changes
associated with receptor function and desensitization do not
alter the binding domain for halothane. Moreover, while
[14C]halothane incorporation demonstrates little subunit se-
lectivity, the labeling pattern within -subunits (presumably
also within other subunits) suggests that most binding oc-
curs at the four putative transmembrane segments, MI–
MIV. Whether halothane penetrates between transmem-
brane sequences to produce significant labeling of the
putative pore-lining MII segments remains unclear. The
kinetics of binding of volatile anesthetics to transmembrane
proteins are largely unknown.
Using 19F nuclear magnetic resonance (NMR) spectros-
copy and gas chromatography (GC), we analyzed the bind-
ing kinetics of isoflurane, currently the most important
clinical anesthetic, to nACh receptors that were purified and
reconstituted in 1,2-dioleoyl-sn-glycero-3-phosphocholine
(DOPC) membranes. Based on a two-site exchange model
between nonspecific and specific binding, chemical shift
and transverse relaxation time (T2) measurements were used
to determine the equilibrium dissociation constant, Kd, and
the dissociation rate constant, k1, of isoflurane binding to
nAChR.
MATERIALS AND METHODS
Previously documented procedures (Ellena et al., 1983) for reconstituting
nAChR into DOPC were adapted as follows. Briefly, the electric organ of
Torpedo nobiliana (Biofish Associates, Georgetown, MA) was freshly
dissected and processed (Chak and Karlin, 1992) to obtain nAChR-rich
membranes, which were frozen at 70°C until use. For purification,
nAChR-rich membranes from 1 kg of electric organ were thawed and
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suspended in 600 ml buffer A (pH 7.4), containing 100 mM NaCl, 10 mM
3-(N-morpholino)propanesulfonic acid (MOPS), 0.1 mM EDTA, and
0.02% sodium azide. All chemicals were obtained from Sigma Chemical
Co. (St. Louis, MO) and used without further purification. The nAChR-rich
membrane suspension was stirred for 2 h in the presence of 1% (w/v)
cholate to solubilize the receptors. The mixture was centrifuged at
256,000  g for 30 min, and the supernatant layer was collected. The
solubilized receptors were divided into two equal portions, and each was
gently stirred for 2 h with 50 ml AffiGel-10 (Bio-Rad Laboratories,
Hercules, CA) that was freshly derivatized with bromoacetylcholine bro-
mide (Research Biochemical International, Natick, MA). The receptor-
containing AffiGel-10 was then packed into a 2.5-cm-diameter glass col-
umn and washed at a rate of 100 ml/h with 1% cholate in buffer A for 2 h,
followed by 0.003% DOPC (Avanti Polar Lipids, Alabaster, AL) and 0.5%
cholate in buffer A for an additional period of 2 h. The nAChRs were then
eluted with buffer A containing 20 mM carbamylcholine chloride, 0.003%
DOPC, and 0.5% cholate. The protein-rich fractions were pooled and
dialyzed for 12 h against six changes of 6 liters of buffer A. The membrane
suspension was then concentrated to a few milliliters using Centriprep-50
(Amicon Inc., Bevery, MA) and stored at 70°C until use. Immediately
before NMR experiments, the reconstituted nAChR-rich membrane sus-
pension was subjected to six cycles of a freeze-thaw process alternating
between liquid nitrogen and room temperature to adjust the vesicle size.
After the precipitation of large vesicle aggregates, the protein content in the
homogeneous vesicle suspension was determined by the bicinchoninic acid
method.
All NMR experiments were conducted using a Chemagnetics CMXW-
400SLI spectrometer (Fort Collins, CO), operating at 377.168 MHz for 19F
resonance. Each NMR sample consisted of a freshly thawed 750-l DOPC
vesicle suspension in a 5-mm-diameter high-precision NMR tube (Wilmad
Glass Co., Buena, NJ) with a total volume of 2500 l (i.e., a vapor space
of 1750 l). NMR samples were prepared in pairs of the same DOPC
concentrations and vesicle sizes, but with and without nAChR. The tem-
perature was maintained at 15°C so that the receptor samples could be
stable throughout the experiments. Isoflurane was added to the NMR
samples with a microsyringe (Hamilton) in steps ranging from 0.03 to 0.2
l. The equilibrium isoflurane concentrations in the membrane suspension
were determined experimentally by NMR, with reference to one of two
external standards containing 0.50 mM and 2.19 mM trifluroacetic acid
(TFA) in 5- and 10-mm NMR tubes, respectively. The 10-mm standard
was used coaxially with the 5-mm sample tube during concentration
calibration. The external TFA resonance also served as a frequency refer-
ence for chemical shift measurements.
If  and f are the
19F resonance frequencies of isoflurane in DOPC
vesicle suspension with and without nAChR, respectively, and b is the
limiting resonance frequency for a hypothetical situation in which all
isoflurane molecules were bound to nAChR, then, for a rapid exchange
model between free and bound isoflurane, the mole fraction of isoflurane
bound to nAChR, Xb, is given by (Xu et al., 1996)
Xb
 f
b f
(1)
From the definition of Kd, it can be shown that
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where [A]0 and [R]0 are the total anesthetic and receptor concentrations,
respectively. Thus, in a two-site free exchange model, expressing 1/( 
f) as a function of the total isoflurane concentration will yield a straight
line, with an x-intercept of Kd. It should be noted that this chemical shift
method for the determination of Kd does not require prior knowledge of Xb.
The binding Kd can also be determined by transverse relaxation time
(T2) measurements based on the rapid exchange model given by the
following equation (Dubois and Evers, 1992; Xu et al., 1996):
T2p  1T2 1T2f
1

T2b 	b
R0
	A0 Kd
 (4)
where [A]0 is the total isoflurane concentration at which T2 is measured,
and Kd is given by the negative intercept on the x axis. A modified
Carr-Purcell-Meiboom-Gill (CPMG) spin-echo method (Meiboom and
Gill, 1958) was used, in which T2 was measured by incrementing the
number of 180° pulses in a pulse train and acquiring a series of free
induction decays at the end of each pulse train. After Fourier transforma-
tion, the spectral intensities (measured as area integration under the peaks)
were fitted to an exponential decay function with respect to the time after
the initial 90° pulse. Parallel T2 measurements were made in paired
samples of the same DOPC concentrations and vesicle size, but with or
without nAChR. The samples without the receptors were used to determine
T2f, the T2 in the absence of receptor binding.
To determine the binding kinetics, T2 was also measured as a function
of spin-echo time, 	cp. The modified CPMG method overcame the hard-
ware limitation at very short 	cp values, so that measurements can be made
at 180°-180° interpulse delays as short as 10 s.
It has been shown (Allerhand and Gutowsky, 1965; Dubois and Evers,
1992; Xu et al., 1996) that in the presence of receptor binding, T2 is given
by
1
T2

1 Xb
T2f

Xb
T2b 	b
 	bXb	1 Xb
	

2f		cp
 (5)
where T2b is the T2 of isoflurane in the receptor-bound state, 
 
2(b–f), 	b is the lifetime of isoflurane in the bound state, and f(	cp) is a
hyperbolic tangent:
f		cp
 1
2	b
	cp
tanh
	cp
2	b
(6)
We measured Xb by using GC (Xu et al., 1996), and determined 
 from
chemical shift measurements (Eq. 1). Nonlinear regression of measured
1/T2 as a function of 1/	cp (Eqs. 5 and 6) will yield the best estimates of T2b
and 	b. The off-rate constant of binding, k1, equals 1/	b by definition, and
the on-rate constant, k1, can be calculated by k1/Kd.
All fitting parameters from linear and nonlinear regression will be
reported as “best estimate  standard error of estimate” (Glantz, 1992).
RESULTS
Three separately prepared batches of reconstituted nAChR-
rich membranes were used for repeated measurements. The
receptor concentrations, as determined by the bicinchoninic
acid method for the homogenous nAChR-rich vesicle sus-
pensions, were 5.8, 10.7, and 14.0 M, respectively. Re-
ceptors reconstituted as described above have been shown
previously to retain all of their functional properties (Ellena
et al., 1983; Chak and Karlin, 1992), including specific
activity for toxin binding and ion flux properties. Figure 1
plots the reciprocal of the frequency change for the triflu-
oromethyl (-CF3) and difluoromethyl (-CHF2) resonance as
a function of isoflurane concentration. Notice the difference
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in the scales of the two y-axes, reflecting a larger frequency
change due to the higher sensitivity of the -CHF2 resonance
to isoflurane concentration. The solid lines are linear least-
squares fits to the data at isoflurane concentrations lower
than 1.5 mM. Linear extrapolation to the x axis (Eq. 3)
yields a Kd of 0.38  0.06 mM (mean  SE) from the -CF3
resonance and 0.34  0.01 mM from the -CHF2 resonance.
The average of the two gives a Kd of 0.36  0.03 mM
(mean  SD). At higher isoflurane concentrations, the data
deviated from the linear relationship predicted by Eq. 3,
indicating a certain degree of saturation at the receptor
binding sites. At the nearly saturating concentration of 2.5
mM, the -CHF2 resonance of isoflurane shifted by 30 and 65
Hz in samples with 5.8 and 14 M nAChR, respectively.
For the latter, the Xb was determined by six independent GC
measurements to be 0.05  0.03 (mean  SEM, n  6).
Using Eq. 1 and   f  65 Hz, it can be estimated that
b  f  1300 Hz. Because of strong partitioning of
isoflurane in lipids, which are used as the control, Xb mea-
surements by GC in samples with lower nAChR concentra-
tions were difficult. However, if one assumes that b  f
for the same resonance does not vary with receptor concen-
trations, then Xb for the sample with 5.8 M nAChR can be
estimated to be 0.023 by using Eq. 1. The results are summa-
rized in Table 1.
Fig. 2 shows stack plots of representative 19F spectra,
acquired with the modified CPMG pulse sequence from
samples without (A) and with 5.8 M nAChR (B). The 	cp
for Fig. 2, A and B was 2 ms and 0.01 ms, respectively, as
indicated by the labels next to the first (bottom) spectrum in
each stack. The subsequent spectra in the stack plots are
acquired at the multiples of 	cp. Thus, spectra in Fig. 2 A
were acquired after 1, 2, 3, 4, 5, 6, and 7 refocus pulses in
2-ms intervals, and those in Fig. 2 B were acquired after 1,
20, 30, 40, 50, 60, and 70 refocus pulses in 0.01-ms inter-
vals. Spectral line broadening due to the presence of recep-
tors is apparent by comparing spectra in Figs. 2, A and B.
The T2 at each 	cp value was determined by fitting the
spectral intensities, such as those in Fig. 2, to an exponential
decay function with respect to the spin-echo time. In the
receptor-free lipid vesicle suspensions, the T2 values of the
-CF3 and -CHF2 resonance were found to be 330 ms and
10 ms, respectively, and were independent of 	cp and
isoflurane concentration. Figure 3 shows the dependence of
-CF3 T2 on isoflurane concentration in the presence of
10.7-M nAChR. At low isoflurane concentrations, the T2
dependence fulfills the linear relationship predicted by Eq.
4. This relationship, however, is violated at higher isoflu-
rane concentrations. The solid line at concentration greater
than 0 mM shows the best fit to the data using the saturation
equation [a  bx/(c  x)], yielding a  1.81  0.13 ms,
b  1.15  0.18 ms, and c  0.22  0.13 mM. The first
derivative of the fitting curve with respect to concentration
at 0 mM defines the slope for the linear extrapolation,
resulting in a Kd of 0.35  0.28 mM from the negative
intercept on the x axis.
Figure 4 depicts the 1/T2  1/	cp dependence of the
-CHF2 resonance for 2.5 mM isoflurane in the presence of
5.8 and 14.0 M nAChR. The solid lines show the three-
parameter (i.e., 	b, T2b, and b  f) nonlinear regression
using Eq. 5. The Xb and b  f values listed in Table 1
were used as the initial estimates. The regression was rap-
idly converged to give a b  f value of 1329  183 Hz
and 1368  238 Hz for the samples with 5.8 M and 14.0
M nAChR, respectively. Both values are in excellent
agreement with the result of 1300 Hz obtained from the
independent GC and chemical shift measurements (Table
1). The best estimates for 	b and T2b are, respectively,
54.6  5.6 (mean  SE) and 29.3  5.1 s in the presence
of 5.8 M nAChR, and 62.0 7.7 and 32.1 6.7 s in the
presence of 14.0 M nAChR. Note that although T2 values
for the two samples differ greatly because of the difference
in receptor concentration, the 	b and T2b values are essen-
tially the same within the experimental error, indicating the
robustness of the approach. Table 2 compares the averaged
kinetic and binding constants of isoflurane binding to
nAChR and to a soluble protein, bovine serum albumin
(BSA) (Xu et al., 1996).
FIGURE 1 Determination of the dissociation constant, Kd, by measure-
ments of NMR resonant frequencies as a function of isoflurane concentra-
tion. Data at concentrations lower than 1.5 mM are fitted by linear least-
squares regression based on a two-site exchange model (Eq. 3).
Extrapolation of the linear fit to the x axis yields Kd. E, -CF3 resonance,
the left y axis; , -CHF2 resonance, the right y axis.
TABLE 1 Measured and calculated Xb and b  f (CHF2)
for 2.5 mM isoflurane
nAChR
(M)
DOPC
(mM)
  f (Hz)
(NMR)
Xb
(GC)
b  f (Hz)
(Eq. 1)
Xb
(Eq. 1)
5.8 1.5 30 — — 0.023
14 1.7 65 0.050 1300 —
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DISCUSSION
A practical challenge faced in studies of volatile anesthetic
interaction with membrane proteins is to distinguish specific
interaction with the protein from nonspecific interaction
with the surrounding lipids. The high sensitivity to nAChR
exhibited by both the resonant frequencies and T2 values of
the isoflurane 19F-NMR allows for quantitative analysis of
binding kinetics that can be directly attributed to the pres-
ence of the receptors in the lipids. The observed association
and dissociation constants, therefore, provide direct mea-
sures of specific binding that occurs either directly on the
receptors themselves, or at particular domains created at the
interface between the receptor and the lipids.
The Kd of specific binding determined in Fig. 1 is within
the clinical concentration range for isoflurane and compa-
rable to the value of 0.18  0.04 mM for halothane binding
FIGURE 2 Representative stack plots of 19F-NMR spectra of isoflurane acquired in the absence (A) and presence (B) of nAChR in DOPC vesicles. The
first (lowest) spectrum in each stack was acquired after a single refocusing pulse at the spin-echo time of 	cp as labeled. The subsequent spectra in the stack
were acquired after multiple refocusing pulses in equal intervals of 	cp. Notice the significant line broadening due to the presence of nAChR.
FIGURE 3 Determination of the dissociation constant, Kd, by 19F T2
measurements of the -CF3 resonance as a function of isoflurane concen-
tration. The 	cp was set at 25 s. The error bars show the standard error
associated with the exponential fitting of individual T2 curves. The solid
line at a concentration greater than 0 mM shows the nonlinear regression,
using a saturation function, [a  bx/(c  x)]. The value of the first
derivative of the regression curve at 0 mM was used as the slope for linear
extrapolation in Kd determination, according to Eq. 4.
FIGURE 4 Dependence of 1/T2 on 1/	cp is used to determine 	b and T2b.
The error bars show the standard errors of mean of multiple measurements
(n 2–5) at each given 	cp. Where there are no error bars, the experiments
were performed only once at those points. The solid lines are best fit to the
data, using Eq. 5. The rate constants from the fitting are summarized in
Table 2.
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to nAChR obtained by photoaffinity labeling (Eckenhoff,
1996b). Although the T2 method for Kd determination (Eq.
4) yielded a similar Kd value by linear extrapolation at very
low isoflurane concentrations (Fig. 3), the method showed a
lower apparent saturation concentration than the chemical
shift method. At first glance, this is rather unexpected
because the T2 method is supposed to be more sensitive to
isoflurane concentration, given the significant difference
between T2b and T2f. The linear relationships predicted by
both the chemical shift (Eq. 3) and T2 (Eq. 4) methods are
derived from a two-site rapid exchange model. Whether a
given exchange rate can be considered to be rapid depends
on the method of measurements. For isoflurane binding to
nAChR, we estimated that the exchange rate is on the order
of 104 to 105 s1 based on the 	b value. This rate is much
greater than the limiting chemical shift difference (103
s1, see Table 1) between the bound and free states, but
comparable to the difference between 1/T2b and 1/T2f (104
s1, see Table 2). Therefore, the rapid exchange condition is
fulfilled for the chemical shift method but only marginally
for the T2 method. It should be noted that in the extreme of
rapid exchange, the T2 relaxation process is governed by the
fast-relaxation component because the exchange allows all
spins to experience the environment causing the fast relax-
ation. The measured T2 is then an average of two T2 com-
ponents weighted by Xb. At the other extreme when the
exchange is slow, one would observe two distinct relaxation
components, or biexponential decay. In such a case, T2
measurement would be dominated by the slow-relaxation
(i.e., sharp) component. For isoflurane binding to nAChR
measured in this study, we have an intermediate situation in
which exchange is sufficient to average two relaxation
components into a single exponential decay, but insufficient
to completely remove the dominance of the sharp spectral
component in the T2 measurements. Thus, unless the isoflu-
rane concentration is significantly smaller than Kd, the mea-
sured T2 is biased by the narrower spectral component in the
intermediate exchange regime. The apparent early satura-
tion shown in Fig. 3 as compared to Fig. 1 reflects the
deviation from the rapid exchange model, in addition to the
possible saturation at a receptor site. In contrast, because the
exchange rate is much greater than the limiting frequency
difference, the deviation from the linear relationship in Fig.
1 reflects the true saturation at the receptor binding sites
(i.e., Xb becomes invariant at high isoflurane concentrations).
There are other practical concerns that favor the chemical
shift method over the T2 method for Kd determination of
anesthetic binding to membrane-associated proteins. For
soluble proteins in large quantities, the T2 method is reliable
(Dubois and Evers, 1992; Xu et al., 1996) as long as the
difference between 1/T2b and 1/T2f is much smaller than the
exchange rate (i.e., in the rapid exchange regime). However,
with membrane-associated proteins where high protein con-
centration is difficult to attain, the T2 method is critically
dependent on the T2 values at low isoflurane concentrations,
at which the measurements are less accurate and are time
consuming. Sample stability is also of some concern when
T2 data acquisition becomes too long. The apparent early
saturation (Fig. 4) due to a biased weighting of the narrower
spectral component (1/T2f) limits the use of T2 values at
higher isoflurane concentrations for Kd determination. In
contrast, even at very low anesthetic concentrations, chem-
ical shift can be measured rapidly and accurately. Another
advantage of using the method of Eq. 3 is that Kd can be
determined solely by chemical shifts, independent of Xb.
Thus, it is preferable to use the chemical shift method of Eq.
3, rather than the T2 method of Eq. 4, for Kd determination
of anesthetic binding to membrane proteins.
From Xb and initial receptor concentrations (Table 1), it
can be estimated that there are on average 9–10 specifically
bound isoflurane molecules per nACh receptor. Assuming
that the binding of isoflurane to nAChR resembles that of
halothane in that subunit selectivity is asbent (Eckenhoff,
1996b), then, for a pentameric channel structure of nAChR,
each subunit on average has at most one specific binding
site for two isoflurane molecules or two specific binding
sites for one isoflurane molecule each. It is interesting to
note that mutagenesis studies (Mihic et al., 1997) have
identified as few as two amino acid residues in glycine or
the GABAA receptor subunit that are essential for the re-
ceptor’s sensitivity to general anesthetics. Given the photo-
labeling finding (Eckenhoff, 1996b) that most halothane
binding to nAChR is in transmembrane domains, it is con-
ceivable that the saturable isoflurane binding identified in
this study also occurs within transmembrane domains.
Although at any given time the majority of isoflurane
molecules are unbound, the presence of nAChR in the
membrane greatly broadens the line width of the isoflurane
resonance (compare stack plots in Fig. 2, A and B). This
indicates that significant immobilization occurs to the
bound isoflurane molecules. The exchange between the
bound and free states is fast enough to result in a partial
averaging effect. The T2 values observed depend, again, on
how rapidly T2 is measured relative to the characteristic
time of the exchange process. As shown in Fig. 4, the
dependence of 1/T2 on 1/	cp can be well characterized by the
exchange model of Eqs. 5 and 6. The nonlinear regression in
Fig. 3 shows that T2b, the T2 of -CHF2 resonance of bound
isoflurane, is 30 s, compared to 10,000 s for the T2 of
the same resonance in receptor-free lipid vesicle suspen-
sions. The reduction in T2 by nearly three orders of magni-
tude suggests that the sites for binding must be rather
TABLE 2 Comparison of isoflurane binding constants to
nAChR and BSA
Kd (mM) 	b (s) T2b (s) k1 (s1) K1 (M1 s1)
nAChR 0.36 58.2 30.8 1.7 104 4.8  107
BSA* 1.3 281 4400 3.6 103 2.7  106
*Taken from Xu et al. (1996).
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structurally suited (or structurally specific) for isoflurane,
because isoflurane molecules are significantly immobilized
once they are bound. It should be noted that high specificity
is not necessarily equivalent to tight binding. In fact, com-
pared with isoflurane binding to BSA (a globular protein),
the binding of isoflurane to the transmembrane nAChR is
nearly diffusion limited, as revealed by our analysis of
binding kinetics. As shown in Table 2, both the on- and
off-rate constants are an order of magnitude faster for
isoflurane binding to nAChR than to BSA. One possible
interpretation is that the anesthetic binding sites are more
easily accessible from the lipid phase to nAChR than from
the aqueous phase to BSA. We showed previously that
anesthetic binding sites are amphipathic in character (Xu
and Tang, 1997; Tang et al., 1997; 1999a,b; Xu et al., 1998).
In globular proteins, such amphipathic sites may be special
folds (Eckenhoff, 1996a; Johansson et al., 1999; Franks et
al., 1998) with hindered access directly from the aqueous
phase. In contrast, in transmembrane proteins, the two-
dimensional lateral diffusion in the lipid bilayer may pro-
vide an effective passage and orienting device for anesthetic
binding to receptor sites. Thus, our finding of rapid binding
kinetics for isoflurane to nAChR may suggest that the
presence of lipids is important for realistically and accu-
rately evaluating the binding kinetics between volatile an-
esthetics and neuronal receptors.
In summary, isoflurane binding to nAChR is specific and
saturable. There are at most two specific binding sites for
each subunit in a pentameric receptor, assuming that the
binding has no subunit preference. The motion of the bound
isoflurane molecules is greatly restricted, as judged by a
decrease in T2 upon binding by nearly three orders of
magnitude. The binding to nAChR is nearly diffusion lim-
ited, in contrast to previous findings with soluble proteins.
Thus, the presence of lipids probably contributes to the
rapid kinetics of binding.
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